Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uday Popat

Showing results (1-10 of 262) with videos related to

Pageof 27
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
A Mildly Symptomatic Middle-Aged Woman with INT-1 Primary MyelofibrosisJacinth Joseph, Uday Popat
Journal of Oncology Practice|July 14, 2016
Allogeneic Hematopoietic Stem-Cell Transplantation in Myelofibrosis: Key Messages for Clinical Practice in the Era of Janus Kinase 1/2 InhibitorsPiyanuch Kongtim, Uday Popat
British Journal of Haematology|August 26, 2004
Haematopoietic stem cell transplantation for autoimmune disorders: the American perspectiveUday Popat, Robert Krance
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Improving Survival After Transplant in MyelofibrosisJacinth Joseph, Uday Popat
American Journal of Hematology|December 21, 2004
Every case of essential thrombocythemia should be tested for the Philadelphia chromosomeLawrence Rice, Uday Popat
Blood Advances|February 17, 2026
When remission alone might be good enoughSteven M Devine, Uday Popat
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Janus Kinase Inhibitors and Stem Cell Transplantation in MyelofibrosisRiad El Fakih, Uday Popat
Blood Advances|February 24, 2026
When remission alone might be good enoughSteven M Devine, Uday Popat
Cancer Treatment Reviews|March 14, 2003
Haemopoietic stem cell transplantation for acute lymphoblastic leukaemiaUday Popat, George Carrum, Helen E Heslop
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromesBetul Oran, Uday Popat, Borje Andersson, et al.
Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
A Mildly Symptomatic Middle-Aged Woman with INT-1 Primary MyelofibrosisJacinth Joseph, Uday Popat
Journal of Oncology Practice|July 14, 2016
Allogeneic Hematopoietic Stem-Cell Transplantation in Myelofibrosis: Key Messages for Clinical Practice in the Era of Janus Kinase 1/2 InhibitorsPiyanuch Kongtim, Uday Popat
British Journal of Haematology|August 26, 2004
Haematopoietic stem cell transplantation for autoimmune disorders: the American perspectiveUday Popat, Robert Krance
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Improving Survival After Transplant in MyelofibrosisJacinth Joseph, Uday Popat
American Journal of Hematology|December 21, 2004
Every case of essential thrombocythemia should be tested for the Philadelphia chromosomeLawrence Rice, Uday Popat
Blood Advances|February 17, 2026
When remission alone might be good enoughSteven M Devine, Uday Popat
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Janus Kinase Inhibitors and Stem Cell Transplantation in MyelofibrosisRiad El Fakih, Uday Popat
Blood Advances|February 24, 2026
When remission alone might be good enoughSteven M Devine, Uday Popat
Cancer Treatment Reviews|March 14, 2003
Haemopoietic stem cell transplantation for acute lymphoblastic leukaemiaUday Popat, George Carrum, Helen E Heslop
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromesBetul Oran, Uday Popat, Borje Andersson, et al.
Pageof 27